These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19473225)

  • 21. Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy.
    Argyriou AA; Polychronopoulos P; Koutras A; Xiros N; Petsas T; Argyriou K; Kalofonos HP; Chroni E
    Eur J Cancer Care (Engl); 2007 May; 16(3):231-7. PubMed ID: 17508942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study.
    Khalefa HG; Shawki MA; Aboelhassan R; El Wakeel LM
    Breast Cancer Res Treat; 2020 Aug; 183(1):117-125. PubMed ID: 32601973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study.
    Mokhtar GM; Shaaban SY; Elbarbary NS; Fayed WA
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):594-600. PubMed ID: 20921909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
    Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
    Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
    Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
    Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy.
    Bandla A; Tan S; Kumarakulasinghe NB; Huang Y; Ang S; Magarajah G; Hairom Z; Lim JSJ; Wong A; Chan G; Ngoi N; Ang E; Lee YM; Chan A; Lee SC; Thakor N; Wilder-Smith E; Sundar R
    Support Care Cancer; 2020 Aug; 28(8):3691-3699. PubMed ID: 31811482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
    Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
    Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation.
    Verstappen CC; Postma TJ; Geldof AA; Heimans JJ
    Anticancer Res; 2004; 24(4):2337-41. PubMed ID: 15330181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of gabapentin for the prevention of paclitaxel induced peripheral neuropathy: A randomized placebo controlled clinical trial.
    Aghili M; Zare M; Mousavi N; Ghalehtaki R; Sotoudeh S; Kalaghchi B; Akrami S; Esmati E
    Breast J; 2019 Mar; 25(2):226-231. PubMed ID: 30773731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial.
    Kanbayashi Y; Sakaguchi K; Ishikawa T; Ouchi Y; Nakatsukasa K; Tabuchi Y; Kanehisa F; Hiramatsu M; Takagi R; Yokota I; Katoh N; Taguchi T
    Breast; 2020 Feb; 49():219-224. PubMed ID: 31901783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of paclitaxel-induced peripheral neuropathy successfully treated by H2-blocker, lafutidine].
    Matsumura T; Imamura H; Kishimoto T; Miyazaki Y; Fujii C; Fujino M; Yasui Y; Anami S; Sumita R; Takada N; Fujita Y; Furukawa H
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1565-8. PubMed ID: 19755835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypersensitivity reactions in paclitaxel treatment of ovarian cancer patients.
    Lehoczky O; Bagaméri A; Udvary J; Pulay T
    J Obstet Gynaecol; 2002 May; 22(3):312-3. PubMed ID: 12521509
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity.
    Lanzani F; Mattavelli L; Frigeni B; Rossini F; Cammarota S; Petrò D; Jann S; Cavaletti G
    J Peripher Nerv Syst; 2008 Dec; 13(4):267-74. PubMed ID: 19192066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with vincristine--associated neurotoxicity.
    Othieno-Abinya NA; Nyabola LO
    East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy-induced peripheral neuropathy.
    Hilkens PH; ven den Bent MJ
    J Peripher Nerv Syst; 1997; 2(4):350-61. PubMed ID: 10975744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients.
    Shigematsu H; Hirata T; Nishina M; Yasui D; Ozaki S
    Support Care Cancer; 2020 Oct; 28(10):5005-5011. PubMed ID: 32036471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats.
    Persohn E; Canta A; Schoepfer S; Traebert M; Mueller L; Gilardini A; Galbiati S; Nicolini G; Scuteri A; Lanzani F; Giussani G; Cavaletti G
    Eur J Cancer; 2005 Jul; 41(10):1460-6. PubMed ID: 15913989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxicity associated with a regimen of carboplatin (AUC 5-6) and paclitaxel (175 mg/m2 over 3 h) employed in the treatment of gynecologic malignancies.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    J Cancer Res Clin Oncol; 2001 Jan; 127(1):55-8. PubMed ID: 11206272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical features of paclitaxel-induced peripheral neuropathy and role of Gosya-jinki-gan].
    Yamamoto T; Murai T; Ueda M; Katsuura M; Oishi M; Miwa Y; Okamoto Y; Uejima E; Taguchi T; Noguchi S; Kurokawa N
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):89-92. PubMed ID: 19151569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study on the relation between cisplatin neuropathy and vitamin E.
    Bove L; Picardo M; Maresca V; Jandolo B; Pace A
    J Exp Clin Cancer Res; 2001 Jun; 20(2):277-80. PubMed ID: 11484987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.